BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15821106)

  • 21. VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways.
    Dickson L; Aramori I; Sharkey J; Finlayson K
    Ann N Y Acad Sci; 2006 Jul; 1070():239-42. PubMed ID: 16888173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).
    Langer I; Gaspard N; Robberecht P
    Br J Pharmacol; 2006 Aug; 148(8):1051-9. PubMed ID: 16783404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional identification of the pituitary adenylate cyclase-activating polypeptide receptor VPAC2 from the frog Rana tigrina rugulosa.
    Hoo RL; Alexandre D; Chan SM; Anouar Y; Pang RT; Vaudry H; Chow BK
    J Mol Endocrinol; 2001 Oct; 27(2):229-38. PubMed ID: 11564605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.
    Nicole P; Lins L; Rouyer-Fessard C; Drouot C; Fulcrand P; Thomas A; Couvineau A; Martinez J; Brasseur R; Laburthe M
    J Biol Chem; 2000 Aug; 275(31):24003-12. PubMed ID: 10801840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor.
    Shreeve SM; Sreedharan SP; Hacker MP; Gannon DE; Morgan MJ
    Biochem Biophys Res Commun; 2000 Jun; 272(3):922-8. PubMed ID: 10860852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.
    Dickson L; Aramori I; McCulloch J; Sharkey J; Finlayson K
    Neuropharmacology; 2006 Nov; 51(6):1086-98. PubMed ID: 16930633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
    Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptor.
    Langlet C; Nachtergael I; Robberecht P; Langer I
    Peptides; 2006 Jul; 27(7):1865-70. PubMed ID: 16554109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors.
    Igarashi H; Ito T; Mantey SA; Pradhan TK; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2005 Oct; 315(1):370-81. PubMed ID: 15994369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VPAC and PAC receptors: From ligands to function.
    Dickson L; Finlayson K
    Pharmacol Ther; 2009 Mar; 121(3):294-316. PubMed ID: 19109992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
    J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning and functional expression of a VIP-specific receptor.
    Zhou H; Huang J; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G728-34. PubMed ID: 16959956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.
    McCulloch DA; Lutz EM; Johnson MS; Robertson DN; MacKenzie CJ; Holland PJ; Mitchell R
    Mol Pharmacol; 2001 Jun; 59(6):1523-32. PubMed ID: 11353814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland.
    Conconi MT; Spinazzi R; Nussdorfer GG
    Int Rev Cytol; 2006; 249():1-51. PubMed ID: 16697281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors.
    Couvineau A; Lacapere JJ; Tan YV; Rouyer-Fessard C; Nicole P; Laburthe M
    J Biol Chem; 2003 Jul; 278(27):24759-66. PubMed ID: 12690118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor.
    Couvineau A; Rouyer-Fessard C; Laburthe M
    Regul Pept; 2004 Dec; 123(1-3):181-5. PubMed ID: 15518910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.